Alzheimer's Disease Treated With Vagus Nerve Stimulation
RecruitingNCT06923007Phase: NAStarted 2025-05-07
Summary
The goal of this clinical trial is to evaluate the safety and efficacy of vagus nerve stimulation (VNS) for treating Alzheimer's disease (AD) in patients aged 50-80 years with mild cognitive impairmen
Eligibility
Sex
ALL
Min Age
50 Years
Max Age
80 Years
Locations
Beijing Tiantan HospitalBeijing, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06923007